Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 22, 2026
The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic Indicator.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 31, 2024
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma.
Journal: Blood cancer journal
Published: July 30, 2024
A Case of Epstein-Barr Virus-Negative Post-transplant Lymphoproliferative Disorder in a Solid Organ Transplant Recipient With Untreated Chronic Hepatitis C.
Journal: Cureus
Published: January 31, 2024
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 17, 2023
Outcomes of allogeneic hematopoietic stem cell transplantation in secondary central nervous system lymphoma: a case series.
Journal: Leukemia & lymphoma
Published: January 17, 2023
The role of transplantation in Hodgkin lymphoma.
Journal: Frontiers in oncology
Published: September 26, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Journal: Cancer discovery
Published: August 30, 2022
Immune tolerance induction through haematopoietic chimerism after kidney donation.
Journal: Lancet (London, England)
Published: January 15, 2022
Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 09, 2021
Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients.
Journal: Blood advances
Published: January 14, 2021
Measurable residual disease in hematopoietic stem cell transplantation-eligible patients with acute myeloid leukemia: clinical significance and promising therapeutic strategies.
Journal: Leukemia & lymphoma
Published: November 03, 2020
Last Updated: 09/26/2026